Data Foundry

Drug recalls 2021

Amlodipine and Olmesartan Medoxomil Tablets 10 mg/20 mg 30 Tablets Rx… — Class II drug recall D-0509-2021

Terminated recall by Cardinal Health Inc., reported 2021-06-02, distributed in FL, GA, SC. CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Recall numberD-0509-2021
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmCardinal Health Inc., Dublin, OH, United States
Recall initiated2021-03-15
Classified2021-05-24
Reported by FDA2021-06-02
Terminated2024-06-17
DistributedFL, GA, SC
Quantity33 bottles
Reason classescgmp, temperature control
NDC33342-0190, 33342-0190-07, 33342-0190-10, 33342-0190-12, 33342-0190-44, 33342-0191, 33342-0191-07, 33342-0191-10, 33342-0191-12, 33342-0191-44, 33342-0192, 33342-0192-07, 33342-0192-10, 33342-0192-12, 33342-0192-44, 33342-0193, 33342-0193-07, 33342-0193-10, 33342-0193-12, 33342-0193-44

Product

Amlodipine and Olmesartan Medoxomil Tablets 10 mg/20 mg 30 Tablets Rx Only NDC 33342-192-07 Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536 Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, India

Reason for recall

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0509-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.